As a leader in its healthcare region for the management of breast and gynecological cancers, the Cancer Control Center of Nice is implementing – in accordance with certain orientations outlined in its 2020-2024 establishment project – an accelerated pathway dedicated to rapid diagnosis and timely management of breast cancers, called “Senoday*.”
Since 2012, the Antoine Lacassagne Center has created a unique architectural unit within the department, bringing together a modern technical platform and all the professionals specializing in breast cancer care. In 2017, the Breast Clinic became the University Institute of Breast and Gynecological Cancer.
This pathway is intended for any patient wishing to consult due to a strong suspicion of breast cancer: a mass discovered upon palpation, unilateral nipple discharge, or axillary adenopathy.
It is also intended for patients with a radiological anomaly diagnosed via mammography or ultrasound (ACR4, ACR5) but who have not yet had a biopsy.
How does the pathway work?
The day begins with a consultation with a breast surgeon who gathers clinical information.
The patient is then referred to the radiologist who performs a complete evaluation (mammography, ultrasound, review of any external images) and a biopsy or cytology if indicated. This sample is sent within the hour to the pathology laboratory for preliminary analysis, when possible.
The patient sees the surgeon again at the end of the morning for the announcement of results and an initial therapeutic approach. If there has been no biopsy, or if a rapid analysis was not possible, the patient is still seen by the surgeon after the imaging consultation.
An appointment is scheduled within 7 days following the reception of the final biopsy results. The final treatment decision will then be defined with the proposals made by the Multidisciplinary Team Meeting.
